Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancer. Twenty-eight patients with advanced colorectal cancer refractory to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results